Questions and controversies about varicella-zoster infections.
Bialecki
C
C
University of Connecticut School of Medicine, Farmington.
Feder
H M
HM
D000212:Acyclovir / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002644:Chickenpox / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission; D002648:Child; D002675:Child, Preschool; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission; D014645:Herpesvirus 3, Human / Q000302:isolation & purification; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007223:Infant; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000635:transmission; D012008:Recurrence; D013997:Time Factors; D014613:Vaccines, Attenuated / Q000008:administration & dosage
D007106:Immune Sera; D014613:Vaccines, Attenuated; C030799:varicella-zoster immune globulin; D000212:Acyclovir